logo-loader
viewMitre Medical

Mitre Medical gears up to treat heart disease patients in US-based study of its Mitral Touch device

Mitre Medical Corp CEO John MacMahon tells Proactive the privately-held group is developing a less invasive and safer approach to treat functional mitral valve regurgitation (MR) in patients with moderate to severe MR.

MacMahon says the group recently announced one-year results of the group's Mitral Touch in European patients, and looks forward to bringing the technology to the US within four different clinical sites.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Anglo Pacific Group announce 'largest ever acquisition' to seize upon...

Anglo Pacific Group PLC's (LON:APF, TSE:APY) Chief Financial Officer Kevin Flynn talks to Proactive London about their deal to acquire a 70% net interest in a stream on cobalt production from the Voisey's Bay mine in Canada. Flynn says this is the 'largest ever acquisition' for the firm and...

37 minutes ago

2 min read